Dr Ajay Mehta

Dr Ajay Mehta is a consultant in clinical oncology, specialising in the treatment of lung, oesophagus and stomach cancers. His NHS base is at the Royal Surrey County Hospital.

Training and Appointment

Dr Ajay Mehta qualified from Guy's Hospital Medical School in 1992. He trained in Oncology at central London hospitals including St Bartholomew’s, Hammersmith, Mount Vernon and the Royal Marsden Hospitals. He was appointed as a Consultant in Clinical Oncology in 2004 and currently practises at the Royal Surrey County Hospital in Guildford where he is also the Lead Clinician for Radiotherapy. He has a BSc in pathology and a diploma in medical ethics.

Dr Mehta offers comprehensive management of lung and upper GI cancers (specifically of the oesophagus and stomach). This involves systemic therapies such as immunotherapy, targeted therapy and chemotherapy.  Dr Mehta’s expertise is in immunotherapy, targeted therapies and combination chemotherapy. He is also proficient in advanced radiotherapy techniques including stereotactic ablative radiotherapy (SABR) which is a highly focussed 5-day radiation treatment for prostate cancer patients; intensity-modulated radiation therapy (IMRT), an advanced type of radiation therapy used to treat cancer and non-cancerous tumours, and image-guided radiation therapy (IGRT), another method of radiation therapy that incorporates imaging techniques during each session, thereby improving the precision and accuracy of treatment delivery.

Research and Publications

He is actively involved in research and is the principle investigator for several national and international clinical trials. He is an examiner for the Royal College of Radiologists and the GMC, as well as for radiotherapy postgraduate exams.  Additionally, he is a representative for the Royal College of Radiologists in junior doctor appraisals (ARCP) and at consultant interviews.

Current Practice

Dr Mehta offers weekly evening clinics at Mount Alvernia Hospital and sees patients in our specialist oncology department, St Martha’s Centre, within which there are nine patient rooms and six pods for chemotherapy.  The Centre provides outpatient and daycase services to patients.  The service is provided by oncology specialist nurses and consultants and covers diagnostics, intravenous and oral chemotherapy, chemotherapy instillations and monoclonal antibodies therapy.  Chemotherapy is given for a number of tumours including breast, urological, prostate, bowel, ovarian, bladder, haematological conditions, upper and lower GI, brain, pancreas, head and neck and melanoma.  There is a specialist oncology physiotherapy service, and patients have access to acupuncture and alternative therapies, as well as dedicated Clinical Nurse Specialists (CNS) who support patients throughout their treatment plan.

• Precision oncology
• Advanced radiotherapy techniques
• Novel therapies
• Chemotherapy

• Royal College of Radiologists